+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vietnam Pharmaceutical Q1/2020

  • PDF Icon

    Report

  • 120 Pages
  • April 2020
  • Region: Vietnam
  • Vietnam Industry Research And Consultant (PI)
  • ID: 5023161
VIETNAM PHARMACEUTICAL INDUSTRY

The pharmaceutical industry of Vietnam uses about xx tons of pharmaceutical materials, of which about xx-xx% of used pharmaceutical materials with imported origin.In 2019, Vietnam imported USD xx million of pharmaceutical raw materials, reducing x % compared to the same period in 2018.

By the end of 2018, there were xx enterprises operating in the manufacturing, pharmaco-chemical and pharmaceutical industries. The total market value of the pharmaceutical industry in 2019 is estimated at x million USD, the proportion of which is mainly from imported pharmaceuticals. Although per capita consumption of Vietnam is growing with CAGR (2012 - 2019) reaching x%. In 2019, pharmaceutical exports are estimated to increase by x% compared to 2018, reaching USD xx million,

Table of Contents

AbbreviationsReport summary
1. Business environment
1.1. Macroeconomic situation
1.2. Legal framework
1.3. Trade Agreements
2. Pharmaceutical Industry Overview
2.1. Global Pharmaceutical Industry
2.1.1. Production - Consumption
2.1.2. Export - Import
2.1.3. Production and Consumption Situation in major countries
2.1.4. Large Enterprises in the world
2.2. Vietnam Pharmaceutical Industry Overview
2.2.1. History of Vietnam Pharmaceutical Industry
2.2.2. Industry Position
2.2.3. Industry Scale and Feature
2.2.4. Value Chain of Vietnam Pharmaceutical Industry
2.2.5. Raw materials
2.2.6. Production technology
2.2.7. R&D
2.2.8. Production
2.2.9. Consumption
2.2.10. Export - Import
2.2.11. Price movements
2.2.12. Distribution system
2.3. Risks and challenges
2.4. Industry planning
2.5. Driving forces and forecast
3. Enterprise analysis
3.1. Profitability Ratios
3.2. Cost structure
3.3. Asset Management Ratios
3.4. Capital Structure
3.5. Solvency
3.6. Return on Investment
4. Appendix of financial statements

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • DHG Pharmaceutical Joint Stock Company
  • TRAPHACO Joint Stock Company
  • Domesco Medical Import Export JSC
  • Imexpharm Pharmaceutical JSC
  • OPC Pharmaceutical JSC
  • S.P.M JSC
  • Vimedimex Medi – Pharma JSC
  • Ha Tay Pharmaceutical JSC
  • Ben Tre Pharmaceutical JSC
  • Lam Dong Pharmaceutical JSC

Methodology

Loading
LOADING...